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Abstract:  
The purpose of present study was to develop once a day sustained release matrix tablet of Quetiapine Fumarate 
by using natural polymer viz. Xanthan gum and isolated fenugreek mucilage. Varying ratios of drug and 
polymer like were selected for sustained release tablet by using direct compression method. After fixing the ratio 
of drug and polymer for Sustain the release of drug up to desired time, the release rates were modulated by 
combination of two different rates controlling material and triple mixture of two different rate controlling 
material. After evaluation of physical properties of tablet, the in vitro release study was performed in 0.1 N HCl 
pH 1.2 for 2 hrs and in phosphate buffer pH 6.8 up to 12 hrs. The effect of polymer concentration and polymer 
blend concentration were studied. Dissolution data was analyzed by Higuchi expression. It was observed that 
matrix tablets contained polymer blend of Xanthan gum and isolated fenugreek mucilage were successfully 
sustained the release of drug up to 12 hrs. Among all the formulations, formulation P3 which contains 15 % 
Xanthan gum and % 25 of fenugreek mucilage release the drug which follow Higuchi kinetics via, diffusion and 
erosion and the release profile of formulation P3 was comparable with the prepared batch products.  
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INTRODUCTION:  
Sustained release (SR) technology has rapidly 
emerged over the past three decades as a new 
interdisciplinary science that offers novel 
approaches to the delivery of bioactive agents into 
systemic circulation at a predetermined rate [4].  
By developing a predictable and reproducible drug 
release rate for an extended period of time, SR 
formulations can achieve optimum therapeutic 
responses, prolonged efficacy and decreased 
toxicity. Hydrophilic matrix tablets are among the 
most popular delivery systems for oral sustained 
release dosage forms through the gastrointestinal 
(GI) route. This is largely because they offer 
precise modulation of drug release as a result of 
hydration of the constituent polymer(s), flexibility 
to obtain the desired drug release profiles, cost 
effectiveness, patient compliance and providing a 
constant, prolonged, and uniform therapeutic effect 
in blood levels of the drug unlike conventional 
systems [5,8]. 
 
The use of hydrophilic polymers for sustained drug 
delivery has attracted the attention of investigators 
in recent years. Among the hydrophilic polymers, 
natural polysaccharides are preferred due to their 
nontoxicity, biocompatibility, biodegradability and 
acceptance by the regulating agencies. 
Polysaccharides, like cellulose ethers, xanthan 
gum, scleroglucan, locust bean gum and guar gum, 
are some of the natural polysaccharides that have 
been evaluated in hydrophilic matrix tablets for 
drug delivery systems [1]. 
 
In the present scenario with the changing life style 
and busy daily tasks people of all age groups are 
suffering from different types of psychological 
disorders and hence there is an increase in demand 
for the psychotropic drugs. In this context many 
novel drugs always try to capture existing markets 
which offer some additional benefits in terms of 
safety, reducing the side effects etc. Quetiapine 
fumarate is one such novel second generation, 
atypical anti psychotic drug often clinically 
recommended in conditions of schizophrenia, 
depression, mania. It interacts with a broad range 
of receptors and antagonizes both dopamine and 
serotonin receptors to alleviate its antipsychotic 
activity [9]. It has mean elimination half life of 6 
hours and hence there is a need for twice or thrice 
daily administration. Hence formulating it into 
sustained release dosage form can increase patient 
compliance and offer clinical safety [8]. 
 
Selections of polymers play an important role in 
designing such a drug delivery systems. 
Hydrophilic natural polymers are one such widely 
employed polymer for controlling the drug release 
[10]. The continual quest and maneuvering in 
exploring novel excipients, natural polymers came  
 
into light with a broad range of advantages. The 
fact for increase in importance of plant based 
natural material is that plant resources are 
renewable and if cultivated or harvested in a 
sustainable manner, they can provide a constant 
supply of raw materials.5,11 
The past researches acknowledge the use of 
fenugreek mucilage as a potential non-toxic and 
safe pharmaceutical excipient in tablet. These 
particular explicate the rational, why proposed 
article concerns the use of fenugreek mucilage for 
sustained drug delivery [11]. 
 
Xanthan gum is another such exocellular 
polysaccharide obtained from Xanthomonas 
campestris and is used in oral, topical 
pharmaceutical formulations, cosmetics and food 
products [11].    
In the present study, it was attempted to develop 
sustained release matrix tablet of Quetiapine 
Fumarate to be taken once a day using combination 
of fenugreek mucilage and xanthan gum with 
different ratio and other excipients Lactose, MCC, 
Magnesium Stearate, and Talc [12]. 
MATERIAL AND METHOD:  
Materials 
Quetiapine Fumarate was gifted by Akums Drugs 
& Pharmaceuticals Ltd, Haridwar. Xanthan gum 
was gifted by Lucid colloids Pvt Ltd, Mumbai. 
Microcrystalline cellulose, Magnesium stearate, 
Talc was gifted by Loba Chemicals, Mumbai. 
Lactose was obtained as MNS Laboratories, Ltd, 
India. Fenugreek mucilage was extracted from 
seeds of Trigonella Foenum- Graecum L., a 
member of the family Fabaceae.  
Tablet were compressed using tablet punching 
machine 8 station (A jaguar) General machinery 
co. Mumbai. India Model no. JMD-4.Analysis was 
performed using UV visible spectrophotometer, 
Thermo Scientifics, 2600, India. 
 
Method  
Isolation of fenugreek mucilage 
Fenugreek seeds (200 g) were soaked in 1.5 L of 
distilled water at room temperature for 1hour and 
then boiled under stirring condition in a water bath 
until the slurry was formed. The solution was 
cooled and kept in a refrigerator overnight to settle 
out undissolved materials. The upper clear solution 
was decanted and centrifuged at 500 rpm for 20 
minutes. The supernatant was separated and 
concentrated at 60oC on was cooled to the room 
temperature and was poured into thrice the volume 
of acetone with continuous stirring. The precipitate 
was washed repeatedly with acetone and dried at 
50-600 C under vacuum. The dried material was 
powdered and kept in a desiccator [14].  
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Characterization of fenugreek mucilage 
Swelling Index 
One gram of powder was placed in a 25 ml ground-
glass- stoppered cylinder graduated over a height of 
about 120 to 134 mm in 5 ml divisions. The 
powder was moistened with 1 ml of ethanol (96% 
v/v), water was added up to 25 ml and the cylinder 
was closed. It was shaken vigorously every 10 min 
for 1 hour and then allowed to stand for 3 hour. 
The volume occupied by the powder was measured 
including any adhering mucilage. Three tests were 
carried out at the same time. Swelling index was 
calculated from the mean of the three tests. 
 
Particle size distribution 
The particle size of the fenugreek mucilage powder 
was analysed by optical microscope. 
 
Flow property of fenugreek mucilage powder 
The flow properties of fenugreek mucilage powder 
were characterized in terms of angle of repose, 
Carr’s index (% Compressibility) and hausner's 
ratio. Angle of repose was measured by direct 
funnel method. The tan-1 of the (height of pile/ 
radious of surface) gave angle of repose.7 
 
 
 
pH 
The pH of each of 1% suspension was measured 
using a pH meter to check any hydrolysis or 
microbial decomposition of suspensions. The 
change in pH is attributed to hydrolysis or 
microbial decomposition.3 
 
Viscosity 
1 gm dried and finely powdered fenugreek 
mucilage was suspended in 75 ml distilled water 
for 5 hour. Distilled water was added upto 100 ml 
to produce the concentration of 1% w/v. The 
mixture was homogenized by mechanical stirrer for 
2 hour and its viscosity was determined using a 
Brookfield viscometer, spindle LV2 at 20 rpm at 
25oC [2]. 
 
Total ash 
The ground air-dried fenugreek mucilage powder 
approximately 3 g was weighed in a previously  
ignited and tarred crucible (usually of platinum or 
silica) and it was ignited by gradually  increasing 
the heat to 500-600°C until it was white which 
indicate the absence of carbon. It was cooled in a 
desiccator and weighed. The content of total ash in 
mg per g of air-dried material was calculated. 
 
Acid-insoluble ash 
To the crucible containing 1 g of total ash, 25 ml of 
hydrochloric acid (~70g/l) was added and it was 
covered with a watch-glass and boiled for 5 
minutes. The watch-glass was rinsed with 5 ml of 
hot water and this liquid was added to the crucible. 
The insoluble matter was collected on an ash less 
filter-paper and washed with hot water until the 
filtrate was neutral. The filter-paper containing the 
insoluble matter to the original crucible was dried 
on a hot-plate and ignited to constant weight. The 
residues were allowed to cool in a suitable 
desiccator for 30 minutes and then weighed. The 
content of acid-insoluble ash in mg per g of air-
dried material was calculated. 
 
Water-soluble ash 
To the crucible containing 1 g of total ash, 25 ml of 
water was added and boiled for 5 minutes. 
Insoluble matter was collected on an ash less filter-
paper, washed with hot water and ignited in a 
crucible for 15 minutes at a temperature not 
exceeding 450°C. The content of water-soluble ash 
in mg per g of air-dried material was calculated by 
subtracting the weight of this residue in mg from 
the weight of total ash. 
 
Drug excipient compatibility studies  
I.R Spectroscopy of Quetiapine Fumarate and 
polymer mixture 
IR spectroscopy is one of the analytical techniques 
useful in detecting chemical interactions. The IR 
spectra of Quetiapine fumarate and formulation 
were determined by FT-IR using KBr dispersion 
method. The base line correction was done using 
dried KBr. Then the spectrum of dried mixture of 
drug and KBr was run on FT-IR JASCO (MODEL 
No.4100).The spectra were scanned over 
wavelength region of 4000 to 400 cm-1. The 
procedure consisted of dispersing a sample (drug 
alone, fenugreek mucilage, xanthan gum & mixture 
of drug and polymer). 
 
Differential Scanning Calorimetric (DSC) 
DSC analysis of pure Quetiapine Fumarate, 
polymer & physical mixture of Quetiapine 
Fumarate with formulation excipients was 
performed using Shimadzu-Thermal Analyzer DSC 
60 on 2-5mg samples. Samples were heated in an 
open aluminum pan at a rate of 10°C/min 
conducted over a temperature range of 40 to 280°C 
under a nitrogen flow of 2-bar pressure. 
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Table No.1: Formulation Table according to 32 factorial designs
 
 
Formulation of tablets  
Tablets were prepared using direct compression 
method. The formulations are composed of various 
concentrations of Xanthan gum and fenugreek 
mucilage in the ratios as drug and polymers in 
various percentages. (Table no.1)  All powders 
were passed through 100- mesh sieve. The lactose 
and the polymer were mixed uniformly. Drug was 
added to the lactose and the polymer mixture and 
the blended for 20 min. Blend were then passed 
through sieve no.12 .The resulting mass were 
mixed with magnesium stearate and talc. The 
lubricated mass was compressed using 12mm die 
punch (KBr Press) in to tablets. Compression 
pressure was adjusted during tableting of each 
formula to get the tablet hardness in the range of 6 
to 7 kg/cm2. The total weight of tablet was kept at 
500 mg [15].   
 
Evaluations of powder blend 
Powder blend was characterized for its flow 
property by evaluating angle of repose, carr’s index 
and hausner’s ratio.  
 
Evaluation of formulation [7,15] 
Weight variation  
In this 20 tablets of each formulation were selected 
and weighed with the use of electron balance. 
Individual tablets were weighed and the individual 
weight was compared with an average weight. 
 
Hardness: 
Tablets were selected at random form each 
formulation and hardness was determined using 
Monsanto Hardness Tester. 
 
Thickness: 
Thickness of tablet was determined using vernier 
caliper. Three tablets from each formulation batch 
were used; mean thickness value and standard 
deviation were calculated. 
 
Friability: 
20 tablets of each formulation were weighed 
accurately and then placed in Roche friablator 
which was rotated for 100 revolutions at 25 rpm. 
Tablets were then dusted and reweighed. 
 
Where, 
F = Friability. W0 = Initial weight of 20 tablets, W 
= Final weight of 20 tablets. 
 
Drug Content: 
Drug content for all formulation batches were 
determined. Five tablets were weighed and crushed 
in glass mortar pestel. The powder was weighed to 
get 100 mg of quetiapine fumarate, and transferred 
to 250 ml of conical flask containing 100 ml of 
phosphate buffer pH 6.8 and stirred for 8 hours on 
magnetic stirrer. Dispersion was filtered through 
Whatman filter paper (0.45μm) and filtrate 
obtained was analyzed spectrophoto-metrically at 
248 nm and drug content was determined. 
 
 
            Formulation 
code 
 
Ingredients 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
F7 
 
F8 
 
F9 
Quetiapine Fumarate 200 200 200 200 200 200 200 200 200 
(mg) 
Xanthan Gum 75 
 
75 75 100 100 100 125 125 125 
Fenugreek Mucilage  75 
 
100 125 75 100 125 75 100 125 
MCC 71 
 
58.5 46 58.5 46 33.5 46 33.5 21 
Lactose 71 
 
58.5 46 58.5 46 33.5 46 33.5 21 
Mg. Stearate  4 
 
4 4 4 4 4 4 4 4 
Talc 4 
 
4 4 4 4 4 4 4 4 
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In Vitro Dissolution study 
In vitro drug release study for the prepared matrix 
tablets were conducted for period of 12 hours using 
a six station USP XXVII type II (paddle) apparatus 
at 37 0C ± 0.5 0C and 50 rpm using 0.1 HCL in the 
initial 2 hours and phosphate buffer solution, pH 
(PBS) till the end of the study, as the dissolution 
media. Dissolution studies were carried out in 
triplicate. A 10 ml aliquot of sample was 
withdrawn at regular time intervals, filtered and 
then these samples were diluted 10 folds with 
dissolution medium and then assayed 
spectrophotometrically at 248 nm. The cumulative 
% drug release was calculated for the formulation 
and the drug [10].  
 
Dissimilarity and Similarity Factors 
Dissimilarity factor (f1) of test product was 
calculated in comparison with reference product to 
observe the dissimilarity in drug release. It 
calculates the percent (%) difference between the 
two curves at each time point and is a measurable 
of the relative error between the two curves.                                   
       f1 = 100*Σ (Rt – Tt)/ Σ Rt 
Where Rt and Tt are the mean % dissolution of 
reference and test product, respectively. 
Where Rt and Tt are the mean % dissolution of 
reference and test product, respectively. 
Similarity factor (f2) is defined as the logarithmic 
reciprocal square root transformation of one plus 
the mean squared difference in percent dissolved 
between the test and the reference products. This 
was calculated to compare the test sample with 
reference release profile.     
f2 = 50 x log10 {100/[1 + 1/n x Σ(Rt – Tt)2]0.5} 
Where n = number of sampling points release data 
were curve fitted using PCP disso software.  
 
 
 
Stability studies 
The formulated Quetiapine fumarate sustained 
release tablet containing 100 mg of drug were kept 
in bottles and stored at 250C-60% RH and 400C - 
75% RH. Tablets were analyzed after three month 
for physical parameter and Thickness, Hardness, 
Friability, % drug content, drug release profile 
[10]. 
 
RESULTS AND DISCUSSION:  
Phytochemical and microbial properties of 
fenugreek mucilage 
A phytochemical and microbial property of 
fenugreek mucilage was studied in that chemical 
properties and other parameters are studied. The 
results are presented in Table no 2, 3. Drug 
excipient compatibility study  
 
Differential Scanning Calorimetric (DSC) 
Thermal analysis of drug was carried out using 
DSC. The DSC curve of Quetiapine Fumarate 
profiles a sharp endothermic peak at 177.06 °C 
corresponding to its melting, and indicating its 
crystalline nature and purity of sample. The heat 
required for melting was -113.95mJ. The DSC 
thermogram is shown in Figure no.1. 
 
FT-IR spectrum   
The FTIR spectra of pure Quetiapine Fumarate 
showed in Figure no.2 peaks at wave numbers (cm-
1) which correspond to the functional groups 
present in the structure of the drug.  The absorption 
bands shown by Quetiapine Fumarate are 
characteristic of the groups present in its molecular 
structure. The IR spectra of QF showed the 
principle peaks at wave numbers 3750, 3080, 2880, 
2380, 1600, 1340, 1030, 791 cm−1. Broad peak at 
3750 cm-1 may be due to O-H stretching, 3080 cm-
1Ar-H stretching and 2880 cm-1 C-H stretching, 
2380 cm-1 may be due to aromatic C=C stretching, 
1600 cm−1 may be due to C-N stretching, 1340 
cm-1 may be due to C-H bending, 1030 cm-1 may 
be due to –C-O-C group, 791 cm-1 may be due to 
substituted benzene ring.  
 
Evaluations of powder blend   
Flowability of powder blend was evaluated by 
determining carr’s index and angle of repose, 
hausner,s ratio as it is prerequisites to obtain solid 
dosage form with an acceptable weight variation. 
 
Table No.4 depicts the result of evaluation 
parameters of powder blend of all formulation. The 
bulk density & tapped density for all formulation 
varied in the range of 0.45 ± 0.01 to 0.51 ± 0.01 
and 0.39 ± 0.01 to 0.44 ± 0.01 respectively. The % 
compressibility for all formulation was found to be 
in the range of 15.90 ± 0.3 to 12.36 ± 0.4.  
Hausner’s ratio for all powder blends was found to 
be in the range 1.25 ± 0.0 to 1.28 ± 0.3, also the 
angle of repose for powder blend of all formulation 
range between 25.50 ± 0.03 and 29.68 ± 0.03.thus, 
it showed that all formulations showed good 
compressibility and good flow properties. Result 
shown in table no.3 
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Table 2: Phytochemical and microbial properties of fenugreek mucilage 
 
Properties  
 
                                    Fenugreek mucilage  
 
Chemical Test  
Reuthenium Red  Red color mucilage present  
Molisch Red Violet ring at junction of two 
liquid presence of carbohydrate  
Fehling Solution  Negative no reducing sugar 
 
 
Other 
Parameters  
Swelling Index 4.3 
Partical Size 47.3  
pH 2 
Viscosity  500 cp 
 
Table 3: Physical properties of fenugreek mucilage 
 
Physical property 
 
Practically found 
value 
Physical property 
 
Practically found 
value 
Carr’s index 15% Water soluble ash 0.35% 
Hausner’s ratio 1.23 Angle of repose 22.250 
Total Ash 0.85% Tapped density 0.66 g/ml 
Acid insoluble ash 0.25% % LOD 0.47% 
 
Table 4: Evaluation of Powder Blend 
 
Formulati
ons 
Angle of Repose 
± SD 
(degrees) 
Bulk Density ± 
SD (gm/ml) 
 
Tapped 
Density± 
SD(gm/ml) 
Compressibility 
Index± SD (%) 
Hausner’s 
Ratio ± SD 
F1 29.68  0.50  0.44  13.5  1.25  
F2 28  0.49  0.43  13.94 0.4 1.28  
F3 27.47  0.51  0.44  15.90  1.25 0.01 
F4 28.30  0.45  0.39 0.01 15.38 0.2 1.27  
F5 27.30   0.49 0.04 0.43 0.03 13.95 0.1 1.26 0.15 
F6 26.40  0.46 0.02 0.41  12.36 0.4 1.25 0.10 
F7 25.50  0.49 0.01 0.43 0.01 14.40 0.1 1.26 0.0 
F8 26.60  0.48 0.03 0.42 0.02 14.28 0.3 1.28 0.3 
F9 28.40  0.04 0.50 0.04 0.44 0.03 13.5 0.01 1.30 0.21 
                  
Table 5: Evaluation of Compressed Tablets 
 
Formulation 
code  
Thickness (mm)  Hardness 
(kg/cm2)  
Wt. variation 
(mg) 
Friability (%)  Drug 
content (%)  
F1  5.4 0.05 6.0 0.01 500 0.15 0.205 97.96 
F2  5.4 0.07 6.0 0.01 498 0.16 0.185 95.03 
F3  5.5 0.04 6.1 0.03 498 0.17 0.235 98.26 
F4  5.4 0.06 6.3 0.04 501 0.15 0.456 95.56 
F5  5.5 0.06 6.0 0.01 505 0.14 0.126 97.03 
F6  5.4 0.07 6.0 0.05 500 0.15 0.354 98.01 
F7  5.4 0.06 6.0 0.01 500  0.235 94.04 
F8  5.4 0.06 6.2 0.02 495 0.17 0.274 95.54 
F9  5.4 0.07 6.1 0.03 498 0.16 0.135 95.23 
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Table 6: Kinetic treatment to dissolution data for SR tablet 
 
Formulat
ions 
 Regression Coefficient (R2) Best fit 
Model Zero order 
Plot 
First order 
Plot 
Korsmeyer- Peppas    Plot Higuchi 
plot (R2) n (release 
exponent) 
F1 0.9735 0.8916 0.8208 0.602 0.9960 Higuchi 
F2 0.9785 0.9985 0.8126 0.633 0.9816 Higuchi 
F3 0.9783 0.8675 0.8126 0.654 0.9941 Higuchi 
F4 0.9776 0.8718 0.8336 0.608 0.9821 Higuchi 
F5 0.9874 0.9161 0.8106 0.632 0.9731 Zero order 
F6 0.9785 0.8983 0.8050 0.661 0.9811 Higuchi 
F7 0.9747 0.9114 0.8357 0.586 0.9876 Higuchi 
F8 0.9863 0.9103 0.8139 0.614 0.9938 Higuchi 
F9 0.9947 0.9734 0.8390 0.583 0.9763 Zero order 
 
 
 
 
Fig.1: DSC of Quetiapine Fumarate  
 
Fig. 2: FT-IR spectrum of (A) pure QF (B) fenugreek mucilage 
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Fig.3: Dissolution profile for all formulation  
 
Evaluation of Compressed Tablets  
Evaluation of compressed tablets in that study 
thickness, hardness, weight variation, friability, and 
drug content. The hardness value of the tablet 
formulation was within the range of 6.0 ± 0.01 to 
6.1 ± 0.03 kg/cm2. The concentration of fenugreek 
mucilage increases there is increases in hardness 
value. Another measure of tablet strength is 
friability.in present study friability was below 1% 
indicating friability was within pharmacopoeia 
limit. Thickness of F1 to F9 formulation was found 
in the range of 5.4 ± 0.07 to 5.5 ± 0.06 mm. Result 
shown in Table no.5 
 
In vitro drug release study  
As the drug in study had a slight solubility in water 
moderate molecular weight Xanthan gum and 
Fenugreek mucilage are used as a rate controlling 
polymers to retard the release of drug from a matrix 
at levels of 15 to 25% w/w in tablets prepared. The 
effect of polymer level on the release of the drug 
from matrix tablets was studied for tablets 
containing 15%, 20% and 25% of the polymer 
(Formulations F1 to F9). The amount of Xanthan 
gum and as well as Fenugreek mucilage used 
affects the release rate of the drug. This may be due 
to the erosion of the polymer as it is of a very low 
viscosity. Thus, indicating that higher the 
percentage of the polymer more is the drug release 
retardation. The obtained release data from the in-
vitro dissolution study from various formulations 
was fitted to the mathematical models. The kinetic 
models included First order, Higuchi equation 
(matrix system) and Korsmeyer- Peppas model. 
Above graph shows the data obtained from the 
model fitting, for all the 9 formulations studied 
(F1-F9). The overall curve fitting showed that the 
drug release from the sustained release matrix 
tablets followed either Higuchi equation or the 
Korsmeyer-Peppas model. 
 
The dissolution data of batches F1 to F9 was fitted 
to Zero order, First order, Higuchi, Hixson crowell 
and Korsmeyer-Peppas models. The coefficient of 
regression (R2) value was used as criteria to choose 
the best model to describe drug release from the 
tablets. The R2 values of various models are given 
in Table no.6 
The mean diffusional exponent values (n) obtained 
from Korsmeyer equation ranged from 0.583 to 
0.661 indicating that all these formulations 
presented a dissolution behavior controlled by Non 
Fickian Diffusion (When n tends towards< 
0.5).The results for formulation F3 with R2 value of 
0.9783 confirmed that the formulation followed 
Higuchi matrix model indicating Quetiapine 
Fumarate release from controlled drug delivery 
system were by both diffusion and erosion 
mechanism. 
 
To confirm the diffusion mechanism the data were 
fitted into korsmeyer-Peppas equation. For matrix 
tablet, n value less than 0.5 indicate fickian 
diffusion and n value in between 0.5 to 1 indicate 
Non-fickian diffusion. (erosion).  
 
Stability study   
The results of accelerated stability studies carried 
out according to ICH guidelines; indicate that 
optimized QF sustained release tablet did not show 
any changes physical parameter and the drug 
content. Furthermore, in vitro release studies 
carried out on the optimized formulation stored at 
accelerated test conditions indicating no 
statistically significant change in the drug release 
profile.  
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CONCLUSION:  
Finally, it may be concluded that the formulations 
prepared with xanthan gum & fenugreek mucilage 
polymer show drug release in 12hrs and 
formulations could retard the drug release up to 
desired time period. The tablets containing polymer 
blend of xanthan gum and fenugreek mucilage 
retard the drug release because both are swellable 
polymer. From the release study it is observed that 
as we increase the concentration of xanthan gum 
the release of drug is decreased. This is possibly 
due to slower erosion of xanthan gum and 
increased viscosity which might have helped to 
keep the hydrated gel intact thus releasing the drug 
for 12 hrs. Among these formulations F3 contain 
the ratio of 15:25 % of xanthan gum: fenugreek 
mucilage showed 95.86% release in 12 hrs and the 
release profile follows higuchi kinetics.  
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